Many Pharma companies have expressed a reluctance or nervousness towards engaging in social media activities. There have been several reasons for this reluctance and we are slowly seeing a resolution to some of these issues. Firstly, there were concerns over the broadcasting of marketing messages to the public. The answer to this has been simple: the guidelines for communication through traditional forms of marketing still stand. In Europe this means no communication of prescription drugs can be aimed at the public. However general company messages and certain over-the-counter (OTC) or non-prescription drug communication is permissible. As a result, companies brave enough to have a social media presence have done so by having a company-based page and posting about their philanthropic efforts, what it’s like to work there and unbiased articles about their company.